Understanding your individual peptide profile and genetic predispositions allows clinicians to monitor mental health proactively and adjust treatment approaches when necessary
This suggests that the GIP receptor could be a potential target for the prevention and treatment of osteoporosis [50], Fig
High dose oral cobalamin would be a reasonable alternative as maintenance in patients unable to tolerate intramuscular injections provided there is good compliance with treatment
iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes
The Journal of Clinical Endocrinology & Metabolism, 105(8), e3000e3002
and has received research support from Boehringer-Ingelheim, Eli Lilly &, Merck, Sharp & Dohme, Novo Nordisk, and Sanofi